Richard Giroux, the Chief Financial Officer of MeiraGTx, recently sold company stock valued at $144,000. The transaction reflects an ongoing trend among executives managing their investment portfolios. Details regarding the exact number of shares sold and the transaction date were not disclosed. Giroux’s decision to sell the stock may have been influenced by various financial strategies or personal considerations. MeiraGTx continues to advance its operations in the biopharmaceutical industry, with its leadership team executing decisions in line with corporate financial strategies.